ExeVir is a series a startup based in Belgium. 1 investor tracked.
ExeVir is a company founded in 2020 headquartered in Belgium. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
single domain antibody therapies providing broad protection against viral infections
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.